Celularity Inc. (CELU)
NASDAQ·Healthcare·Biotechnology
$1.29
+12.61%
Mkt Cap $37.34M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+132.6%
Consensus $3.00 vs current $1.29
NASDAQ·Healthcare·Biotechnology
$1.29
+12.61%
Mkt Cap $37.34M
No recent rating data.
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
+132.6%
Consensus $3.00 vs current $1.29